首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal KIAA1967 Antibody

  • 中文名: KIAA1967抗体
  • 别    名: DBC1; DBC-1; NET35; p30DBC; p30 DBC
货号: IPD20439
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 1/500 - 1/2000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/200 - 1/1000 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 1/200 - 1/400 Human,Mouse,Rat
Elisa 1/10000 Human,Mouse,Rat

产品详情

参考文献

以下是关于KIAA1967抗体的虚构参考文献示例(请注意,以下内容为模拟创作,实际文献可能需要通过学术数据库核实):

1. **文献名称**: "KIAA1967 Expression Correlates with Aggressive Phenotypes in Breast Cancer"

**作者**: Yamada T, et al. (2018)

**摘要**: 通过免疫组化(IHC)和Western blot分析,发现KIAA1967在乳腺癌组织中高表达,且与肿瘤侵袭和患者生存率下降显著相关。研究使用特异性抗体证实其定位在细胞质,可能通过调控细胞迁移通路发挥作用。

2. **文献名称**: "KIAA1967 in Neuronal Migration: Insights from Antibody-Based Knockdown Studies"

**作者**: Smith JL, et al. (2020)

**摘要**: 利用KIAA1967抗体进行免疫荧光和功能实验,揭示该蛋白在小脑颗粒神经元迁移中的关键作用。抗体介导的蛋白抑制导致迁移缺陷,提示其在神经发育中的潜在机制。

3. **文献名称**: "Prognostic Value of KIAA1967 in Colorectal Cancer: A Tissue Microarray Study"

**作者**: Lee H, et al. (2019)

**摘要**: 通过组织芯片结合抗体验证,发现KIAA1967在结直肠癌中表达上调,与淋巴结转移和晚期分期相关,提示其作为潜在生物标志物的价值。

4. **文献名称**: "KIAA1967 Interacts with β-Catenin in Hepatocellular Carcinoma Progression"

**作者**: Chen R, et al. (2021)

**摘要**: 使用Co-IP和抗体阻断实验,证明KIAA1967与Wnt/β-catenin通路相互作用,促进肝癌细胞增殖和转移,为靶向治疗提供新思路。

**注意**:以上内容为示例性质,实际文献需通过PubMed、Google Scholar等平台检索确认。建议结合具体研究领域进一步筛选。

背景信息

The KIAA1967 antibody is a research tool designed to target the KIAA1967 protein, a less characterized gene product encoded by the KIAA1967 gene (also known as CCDC36 or C12orf29). This gene is conserved across species and has been implicated in various cellular processes, including DNA repair, chromatin remodeling, and cell cycle regulation. The protein is believed to play a role in maintaining genomic stability, though its exact molecular mechanisms remain under investigation. KIAA1967 antibodies are typically developed as polyclonal or monoclonal antibodies, often raised in rabbits or mice using immunogenic peptides or recombinant protein fragments. They are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to study the protein's expression, localization, and interaction partners in cell lines or tissue samples. Some studies suggest KIAA1967 may be dysregulated in cancers, such as breast or ovarian tumors, linking it to oncogenic pathways. Validation of these antibodies often includes knockout cell line controls or siRNA knockdown to confirm specificity. Commercial suppliers provide KIAA1967 antibodies with varying validation data, requiring careful optimization for experimental conditions. Ongoing research aims to clarify its biological roles and potential therapeutic relevance in human diseases.

客户数据及评论

折叠内容

大包装询价

×